EFFECTIVENESS AND SAFETY OF INSULIN GLARGINE 300 U/ML (GLA-300) IN INSULIN-NAIVE PEOPLE WITH TYPE 2 DIABETES AND RENAL IMPAIRMENT: A SUBGROUP ANALYSIS OF ATOS STUDY

被引：0

作者：

Tirosh, A. ^{[1
]}

Khan, N. ^{[2
]}

Vargas-Uricoechea, H. ^{[3
]}

Mabunay, M. A. N. ^{[4
]}

Coudert, M. ^{[5
]}

Pilorget, V. ^{[6
]}

Galstyan, G. ^{[7
]}

机构：

[1] Tel Aviv Univ, Div Endocrinol Diabet & Metab, Chaim Sheba Med Ctr, Tel Hashomer, Israel

[2] Imperial Coll London, Ctr Diabet, Al Ain, U Arab Emirates

[3] Univ Cauca, Dept Internal Med, Popayan Cauca, Colombia

[4] Sanofi, Gen Med, Singapore, Singapore

[5] Sanofi, Biostat & Programming, Paris, France

[6] Sanofi, Diabet & Cardiovasc Dev R&D, Paris, France

[7] Minist Russian Federat, Endocrinol Res Ctr Hlth Care, Diabet Foot Dept, Moscow, Russia

来源：

DIABETES TECHNOLOGY & THERAPEUTICS | 2022年 / 24卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

EP049 / #2

引用

页码：A100 / A101

页数：2

共 50 条

[21] EFFECTIVENESS AND SAFETY OF INSULIN GLARGINE 300 U/ML IN INSULIN-NAIVE PATIENTS WITH TYPE 2 DIABETES (T2DM): POSTHOC ANALYSIS OF THE UKRAINIAN POPULATION FROM ATOS STUDY.
Sokolova, L.
DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A99 - A100
[22] Controlling glycemic variability in people living with type 1 diabetes receiving insulin glargine 300 U/mL (Gla-300)
Mader, Julia K.
Goelz, Stefan
Bilz, Stefan
Bramlage, Peter
Danne, Thomas
BMJ OPEN DIABETES RESEARCH & CARE, 2022, 10 (04)
[23] EASE OF USE OF THE NEW INSULIN GLARGINE 300 U/ML PEN INJECTOR IN INSULIN-NAIVE PEOPLE WITH TYPE 2 DIABETES
Pohlmeier, H.
Klonoff, D.
Berard, L.
Brulle-Wohlhueter, C.
Wu, J.
Dahmen, R.
Nowotny, I.
DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A18 - A19
[24] Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Insulin-Naïve People with Type 2 Diabetes: the ATOS Study
Gagik R. Galstyan
Amir Tirosh
Hernando Vargas-Uricoechea
Maria Aileen Mabunay
Mathieu Coudert
Mubarak Naqvi
Valerie Pilorget
Niaz Khan
Diabetes Therapy, 2022, 13 : 1187 - 1202
[25] Device-supported vs routine titration of insulin glargine 300 U/ml (Gla-300) in type 2 diabetes: efficacy and safety
Flacke, F.
Edelman, S.
Bain, S.
Hasslacher, C.
Charpentier, G.
Vespasiani, G.
Goyeau, H.
Woloschak, M.
Davies, M.
DIABETOLOGIA, 2017, 60 : S307 - S307
[26] Effectiveness and safety of insulin glargine Gla-300 in insulin-naive type 2 diabetes subjects in a real-life setting-the GOAL_RO trial
Stegaru, Daniela
Nicodim, Simona
Vladu, Delia
Gutu, Olimpia
Onaca, Adriana
Pirvu, Florina
Moise, Mihaela
Guja, Cristian
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (02)
[27] Ease of Use of the New Insulin Glargine 300 U/mL SoloSTAR Pen Injector in Insulin-Naive People with Type 2 Diabetes
Pohlmeier, Harald
Klonoff, David C.
Berard, Lori
Brulle-Wohlhueter, Claire
Wu, Junlong
Dahmen, Raphael
Nowotny, Irene
DIABETES, 2015, 64 : A269 - A270
[28] Efficacy and safety of insulin glargine 300 U/mL versus insulin glargine 100 U/mL in Asia Pacific insulin-naive people with type 2 diabetes: The EDITION AP randomized controlled trial
Ji, Linong
Kang, Eun Seok
Dong, XiaoLin
Li, Ling
Yuan, GuoYue
Shang, Shuhua
Niemoeller, Elisabeth
DIABETES OBESITY & METABOLISM, 2020, 22 (04): : 612 - 621
[29] Italian Titration Approach Study (ITAS) with insulin glargine 300 U/mL in insulin-naive type 2 diabetes: Design and population
Bonadonna, R. C.
Giaccari, A.
Buzzetti, R.
Aimaretti, G.
Cucinotta, D.
Avogaro, A.
Perseghin, G.
Larosa, M.
Bolli, G. B.
Fanelli, C. G.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2019, 29 (05) : 496 - 503
[30] New insulin glargine 300 U/ml: glycaemic control and hypoglycaemia in insulin-naive people with type 2 diabetes mellitus (EDITION 3)
Bolli, G. B.
Riddle, M. C.
Bergenstal, R. M.
Ziemen, M.
Sestakauskas, K.
Goyeau, H.
Home, P. D.
DIABETOLOGIA, 2014, 57 : S387 - S388

← 1 2 3 4 5 →